ELAN ALERT: Rigrodsky Law, P.A. Is Investigating Elanco Animal Health Incorporated On Behalf of Shareholders
Rigrodsky Law, P.A. has announced an investigation into potential claims against the officers and directors of Elanco Animal Health Incorporated (NYSE:ELAN) on behalf of stockholders. The investigation concerns shareholders who purchased or acquired Elanco shares on or before November 7, 2023. Interested parties are encouraged to visit the law firm's website or contact Leah Wihtelin for more information about the investigation and their rights. This announcement suggests possible legal action related to Elanco's corporate governance or business practices, which could potentially impact shareholders.
Rigrodsky Law, P.A. ha annunciato un'indagine su possibili reclami contro gli ufficiali e i direttori di Elanco Animal Health Incorporated (NYSE:ELAN) per conto degli azionisti. L'indagine riguarda gli azionisti che hanno acquistato o acquisito azioni Elanco entro il 7 novembre 2023. Le parti interessate sono incoraggiate a visitare il sito web dello studio legale o a contattare Leah Wihtelin per ulteriori informazioni sull'indagine e sui propri diritti. Questo annuncio suggerisce una possibile azione legale relativa alla governance aziendale o alle pratiche commerciali di Elanco, che potrebbe potenzialmente influenzare gli azionisti.
Rigrodsky Law, P.A. ha anunciado una investigación sobre posibles reclamaciones contra los oficiales y directores de Elanco Animal Health Incorporated (NYSE:ELAN) en nombre de los accionistas. La investigación se refiere a los accionistas que compraron o adquirieron acciones de Elanco en o antes del 7 de noviembre de 2023. Se alienta a las partes interesadas a visitar el sitio web del bufete de abogados o a contactar a Leah Wihtelin para obtener más información sobre la investigación y sus derechos. Este anuncio sugiere una posible acción legal relacionada con la gobernanza corporativa o las prácticas comerciales de Elanco, lo que podría afectar potencialmente a los accionistas.
리그로드스키 법률 사무소(P.A.)는 주주를 대신하여 엘란코 동물 건강 주식회사(NYSE:ELAN)의 임원 및 이사에 대한 잠재적인 청구에 대한 조사를 발표했습니다. 이 조사는 2023년 11월 7일 이전에 엘란코 주식을 매입 또는 취득한 주주와 관련이 있습니다. 관심 있는 당사자는 법률 사무소의 웹사이트를 방문하거나 리아 위첼린(Leah Wihtelin)에게 연락하여 조사 및 권리에 대한 추가 정보를 얻을 것을 권장합니다. 이 발표는 엘란코의 기업 거버넌스 또는 비즈니스 관행과 관련된 법적 조치의 가능성을 시사하며, 이는 주주에게 잠재적으로 영향을 미칠 수 있습니다.
Rigrodsky Law, P.A. a annoncé une enquête sur d'éventuelles réclamations contre les dirigeants et administrateurs de Elanco Animal Health Incorporated (NYSE:ELAN) au nom des actionnaires. L'enquête concerne les actionnaires qui ont acheté ou acquis des actions d'Elanco au plus tard le 7 novembre 2023. Les parties intéressées sont encouragées à visiter le site Web du cabinet d'avocats ou à contacter Leah Wihtelin pour plus d'informations sur l'enquête et leurs droits. Cette annonce suggère une éventuelle action en justice liée à la gouvernance d'entreprise ou aux pratiques commerciales d'Elanco, ce qui pourrait potentiellement avoir un impact sur les actionnaires.
Die Rigrodsky Law, P.A. hat eine Untersuchung zu möglichen Ansprüchen gegen die Führungskräfte und Direktoren von Elanco Animal Health Incorporated (NYSE:ELAN) im Auftrag der Aktionäre angekündigt. Die Untersuchung betrifft Aktionäre, die Elanco-Aktien am oder vor dem 7. November 2023 gekauft oder erworben haben. Interessierte Parteien werden ermutigt, die Website der Kanzlei zu besuchen oder Leah Wihtelin für weitere Informationen zur Untersuchung und ihren Rechten zu kontaktieren. Diese Ankündigung deutet auf mögliche rechtliche Schritte in Bezug auf die Unternehmensführung oder Geschäftspraktiken von Elanco hin, die möglicherweise Auswirkungen auf die Aktionäre haben könnten.
- None.
- None.
WILMINGTON, DE / ACCESSWIRE / October 22, 2024 / Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE:ELAN) on behalf of stockholders.
If you purchased or otherwise acquired Elanco shares on or before November 7, 2023 and want to learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-elanco-animal-health-incorporated. You may also contact Leah Wihtelin cost free at (516) 693-8926 or by email at lw@rl-legal.com.
About the Investigation:
The investigation concerns whether Elanco and certain of its directors and/or officers issued materially misleading information and/or failed to disclose material information to the investing public. Specifically, the investigation concerns whether Elanco and certain of its directors and/or officers failed to disclose to shareholders, among other things, that: (i) one of the Company's proprietary products, Zenrelia, was less safe than the Company claimed; (ii) Elanco was unlikely to meet its previously-announced timeline for U.S. approval and commercial launch of Zenrelia and another one of the Company's products, Credelio Quattro; and (iii) as a result, the Company's business and/or financial prospects were overstated.
About Rigrodsky Law:
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.
Attorney advertising. Prior results do not guarantee a similar outcome.
Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: info@rl-legal.com
SOURCE: Rigrodsky Law, P.A.
View the original press release on accesswire.com
FAQ
What is the purpose of Rigrodsky Law's investigation into Elanco Animal Health (ELAN)?
How can Elanco (ELAN) shareholders learn more about the investigation?
What is the cutoff date for Elanco (ELAN) shareholders affected by this investigation?
Who is conducting the investigation into Elanco Animal Health (ELAN)?
